Skip to main content

Pancreatic Rest - The cure to Diabetes type 2

Shocked?

Well apparently the cure to Diabetes Mellitus or Type 2 Diabetes has been in front of our eyes all along.

Type 2 diabetes, is a condition where the body fails to regulate the sugar levels in the blood causes too much or too little insulin to be produced by the pancreas. It usually turns into a life long disease requiring diet control and insulin therapy.

According to new research, conducted at McMaster university in Canada, there may be hope for type 2 suffers through an intensive program that involves closely monitoring of diet+exercises+insulin+oral medicines. It basically involves giving rest to your pancreas after which your pancreases returns to normal (according to 40% of the results of study) and you are cured of diabetes or your diabetes is reversed, atleast temporarily.

Here are some of the numbers as shared by McMaster University Research Program:

41% of the participants saw their diabetes reverse in just four months after the intensive program.

The trial involved creating a personalized exercise regime for each participant and reducing their calories by between 500 and 750 a day. Participants also met regularly with a nurse and dietitian to track progress and continued to take medication and insulin to manage their blood sugar levels.


If this research and program proves to be successful, it would mean a paradigm shift in treatment of diabetes from that of glucose monitoring and insulin administration to that of reversing or healing the condition entirely and then monitoring for a relapse. 

Comments

Popular posts from this blog

White House annouces private sector actor to reduce organ transplant waitlist

The White House today made an announcement that will affect thousands of organ transplant recipeints in USA to reduce their waiting time and enable to the number of transplants per day to increase dramatically.  According to research 100% of USA population favours Organ donation and would be ready to donate their organs but only 50% end up doing so.  So according to the three pronged approach initiated by Mr. Barack Obama includes developments in the following three areas has been considered:  1. Development of New Technologies  One the first announcements was to support newer technologies that would allow for organ replacment in the future with new tissue development and other technologies like 3D printing.  "New breakthroughs in bioengineering, transplantation, and organ preservation can further increase the number of organ transplants and improve outcomes," the President's office said. 2. Reducing time taken for Donor Organ...

5 questions about Artificial Implantable Kidney to understand it better

Source - http://timesofindia.indiatimes.com/india/artificial-kidney-may-hit-market-by-end-of-decade/articleshow/56801777.cms What is it? An implantable kidney that works due to silicon microchips. These microchips will house living kidney cells that will grow on an around the microchips. These cells will then mimic the natural action of the kidney. How does it work?  It will work in the same way that a regular kidney works with the patients blood flow. The living kidney cells will create membrane that will filter your blood the way a normal kidney does. Also because it is out of reach from the bodys immune system response it cannot be rejected as with an organ transplant. Who is making it? It is being developed by University of California San Francisco (Shuvo Ray) and Vanderbilt University Medical Centre, Nephrology (William H Fissel). Fissell has been working on the implantable artificial kidney for more than a decade with University of California San Franc...

Prices of Immunosuppressants drop in India

There is finally some good news for transplant patients in India. The National Pharmacuetical pricing authority of India has reduced some of the cost of major immunosuppresants by almost 20-50%.  The most important among these is Prograf and Pangraf one of the main immunosuppresant for Kidney Transplant Patients. The cost of dailysis, transplant and the follow up medicine is too prohibitve for many Indian patients. further low education and awareness levels contributed to patients skipping medicine to save money or taking them only every altrernate day. A lot others preffered to stay on dailysis due to not being able to afford the cost of transplant and better medicines. While the cost of Tacrolimus has been dractically reduced the other drugs by Roche and Novartis haven't seen as much reduction. We hope the government will be able to bring down the price of all the drugs and blood tests realted to transplant and give a huge boost to organ donation in India.  Fruth...